Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes.

Yamani, M H; Avery, R; Mawhorter, S; Young, J B; McNeill, A; Cook, D J; Ratiff, N B; McCarthy, P; Starling, R C

Yamani, M H; Avery, R; Mawhorter, S; Young, J B; McNeill, A; Cook, D J; Ratiff, N B; McCarthy, P; Starling, R C.

Affiliation

Yamani MH; Departament of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA. yamanim@ccf.org

Transpl Infect Dis ; 3 Suppl 2: 40-3, 2001.

Article in En | MEDLINE | ID: mdl-11926749

Subject(s)

Agammaglobulinemia/drug therapy; Antiviral Agents/therapeutic use; Cytomegalovirus Infections/immunology; Cytomegalovirus Infections/prevention & control; Graft Rejection; Heart Transplantation/adverse effects; Immunoglobulins/therapeutic use; Adult; Agammaglobulinemia/etiology; Aged; Cytomegalovirus/isolation & purification; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Immunoglobulins / Heart Transplantation / Cytomegalovirus Infections / Agammaglobulinemia / Graft Rejection Type of study: Etiology_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links